Anne E Cress

12PUBLICATIONS
52CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsTumour immunologyPredictive and prognostic markersHealth and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 13, 2025
Increased Kindlin-2 via SMURF1 Inhibition Attenuates Endothelial Permeability and Acute Lung Injury.

Weiguo Chen, Yulia Epshtein, Christen Vagts

|Feb 21, 2025
Inhibition of PIM Kinase in Tumor-Associated Macrophages Suppresses Inflammasome Activation and Sensitizes Prostate Cancer to Immunotherapy.

Amber N Clements, Andrea L Casillas, Caitlyn E Flores

|Nov 01, 2024
Inhibition of PIM kinase in tumor associated macrophages suppresses inflammasome activation and sensitizes prostate cancer to immunotherapy.

Amber N Clements, Andrea L Casillas, Caitlyn E Flores

|Apr 12, 2023
PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion.

Corbin C Jensen, Amber N Clements, Hope Liou

|Mar 25, 2022
GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors.

John M Ryniawec, Matthew R Coope, Emily Loertscher

|Feb 15, 2022
eNAMPT Is a Novel Damage-associated Molecular Pattern Protein That Contributes to the Severity of Radiation-induced Lung Fibrosis.

Alexander N Garcia, Nancy G Casanova, Carrie L Kempf

Pageof 2